Tanguy Boissenot

Title: Tanguy Boissenot: Innovator in Polymeric Prodrugs

Introduction

Tanguy Boissenot is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of polymeric prodrugs. His innovative work addresses challenges associated with the administration of active molecules that are typically problematic or impossible to deliver via traditional methods.

Latest Patents

Tanguy Boissenot holds a patent for "Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof." This invention relates to new prodrugs of active molecules that facilitate subcutaneous or intramuscular administration, especially for those active molecules that pose toxicity issues at the injection site. The prodrugs consist of an active ingredient covalently linked to a polymer chain, which is preferably hydrophilic and/or thermosensitive. The patent details the structure of these polymeric prodrugs, which may include a polymer chain formed from acrylamide monomer or its derivatives, with a first pharmaceutically active molecule coupled to the proximal part of the polymer and potentially a second active molecule at the terminal part.

Career Highlights

Throughout his career, Tanguy Boissenot has been associated with prestigious institutions such as Université Paris-Saclay and the Centre National de la Recherche Scientifique. His work has significantly advanced the understanding and application of polymeric prodrugs in medical treatments.

Collaborations

Tanguy has collaborated with notable colleagues, including Julien Nicolas and Alexandre Bordat. Their joint efforts have contributed to the development of innovative solutions in the pharmaceutical field.

Conclusion

Tanguy Boissenot's contributions to the field of polymeric prodrugs exemplify the importance of innovation in addressing complex medical challenges. His work continues to influence the development of safer and more effective drug delivery systems.